Showing results (11-20 of 69) with videos related to
Sort By:
Pageof 7
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|November 1, 2023
[Devices and attempts to make understand horizontally and vertically for pharmacology education in Osaka Metropolitan University]Shuhei Tomita, Shinji Matsunaga, Takehiro YamaguchiJournal of Alzheimer'S Disease : JAD|August 7, 2016
Yokukansan in the Treatment of Behavioral and Psychological Symptoms of Dementia: An Updated Meta-Analysis of Randomized Controlled TrialsShinji Matsunaga, Taro Kishi, Nakao IwataPlos One|April 11, 2015
Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysisShinji Matsunaga, Taro Kishi, Nakao IwataPlos One|August 29, 2015
Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled TrialsTaro Kishi, Shinji Matsunaga, Nakao IwataSchizophrenia Bulletin|April 18, 2016
Mortality Risk Associated With Long-acting Injectable Antipsychotics: A Systematic Review and Meta-analyses of Randomized Controlled TrialsTaro Kishi, Shinji Matsunaga, Nakao IwataEuropean Archives of Psychiatry and Clinical Neuroscience|June 20, 2016
Efficacy and tolerability of Z-drug adjunction to antidepressant treatment for major depressive disorder: a systematic review and meta-analysis of randomized controlled trialsTaro Kishi, Shinji Matsunaga, Nakao IwataThe International Journal of Neuropsychopharmacology|December 31, 2014
Combination therapy with cholinesterase inhibitors and memantine for Alzheimer's disease: a systematic review and meta-analysisShinji Matsunaga, Taro Kishi, Nakao IwataJournal of Alzheimer'S Disease : JAD|June 4, 2019
Efficacy and Safety of Glycogen Synthase Kinase 3 Inhibitors for Alzheimer's Disease: A Systematic Review and Meta-AnalysisShinji Matsunaga, Hiroshige Fujishiro, Hajime TakechiNeuropsychiatric Disease and Treatment|August 10, 2017
The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysisTaro Kishi, Shinji Matsunaga, Nakao IwataNeuropsychiatric Disease and Treatment|March 12, 2015
Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trialsTaro Kishi, Yuki Matsuda, Shinji Matsunaga, et al.Pageof 7